Janux Therapeutics Inc (JANX)
48.02
+0.92
(+1.95%)
USD |
NASDAQ |
Apr 26, 13:17
Janux Therapeutics Price to Book Value: 7.204 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 7.066 |
| April 24, 2024 | 7.233 |
| April 23, 2024 | 7.468 |
| April 22, 2024 | 7.333 |
| April 19, 2024 | 7.305 |
| April 18, 2024 | 7.329 |
| April 17, 2024 | 7.195 |
| April 16, 2024 | 7.584 |
| April 15, 2024 | 7.780 |
| April 12, 2024 | 7.899 |
| April 11, 2024 | 7.501 |
| April 10, 2024 | 6.694 |
| April 09, 2024 | 6.005 |
| April 08, 2024 | 5.795 |
| April 05, 2024 | 5.269 |
| April 04, 2024 | 5.311 |
| April 03, 2024 | 5.452 |
| April 02, 2024 | 5.381 |
| April 01, 2024 | 5.654 |
| March 28, 2024 | 5.648 |
| March 27, 2024 | 5.689 |
| March 26, 2024 | 5.827 |
| March 25, 2024 | 5.780 |
| March 22, 2024 | 5.930 |
| March 21, 2024 | 5.978 |
| Date | Value |
|---|---|
| March 20, 2024 | 5.870 |
| March 19, 2024 | 5.795 |
| March 18, 2024 | 5.822 |
| March 15, 2024 | 5.918 |
| March 14, 2024 | 5.666 |
| March 13, 2024 | 5.989 |
| March 12, 2024 | 5.825 |
| March 11, 2024 | 5.996 |
| March 08, 2024 | 5.972 |
| March 07, 2024 | 6.092 |
| March 06, 2024 | 6.311 |
| March 05, 2024 | 6.353 |
| March 04, 2024 | 6.260 |
| March 01, 2024 | 6.403 |
| February 29, 2024 | 6.498 |
| February 28, 2024 | 6.259 |
| February 27, 2024 | 6.682 |
| February 26, 2024 | 2.028 |
| February 23, 2024 | 2.108 |
| February 22, 2024 | 1.962 |
| February 21, 2024 | 1.765 |
| February 20, 2024 | 1.338 |
| February 16, 2024 | 1.267 |
| February 15, 2024 | 1.276 |
| February 14, 2024 | 1.214 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7737
Minimum
Nov 09 2023
7.899
Maximum
Apr 12 2024
2.138
Average
1.772
Median
Dec 03 2021
Price to Book Value Benchmarks
| Viking Therapeutics Inc | 8.488 |
| Equillium Inc | 2.702 |
| Minerva Neurosciences Inc | -- |
| Arvinas Inc | 3.337 |
| Calidi Biotherapeutics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 261.43 |
| Price | 48.02 |
| Earnings Yield | -2.77% |
| Market Cap | 2.481B |